发明申请
US20070105881A1 6-Arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
有权
6-芳基氨基-5-氰基-4-嘧啶酮作为pde9a抑制剂
- 专利标题： 6-Arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
- 专利标题（中）： 6-芳基氨基-5-氰基-4-嘧啶酮作为pde9a抑制剂
-
申请号： US10559954申请日： 2004-06-16
-
公开(公告)号： US20070105881A1公开(公告)日： 2007-05-10
- 发明人: Martin Hendrix , Lars Barfacker , Bettina Beyreuther , Ulrich Ebert , Christina Erb , Frank-Thorsten Hafner , Heike Heckroth , Yan-Hong Liu , Dagmar Karthaus , Adrian Tersteegen , Franz-Josef van der Staay , Marja van Kampen
- 申请人： Martin Hendrix , Lars Barfacker , Bettina Beyreuther , Ulrich Ebert , Christina Erb , Frank-Thorsten Hafner , Heike Heckroth , Yan-Hong Liu , Dagmar Karthaus , Adrian Tersteegen , Franz-Josef van der Staay , Marja van Kampen
- 申请人地址： DE Leverkusen 51368
- 专利权人： Bayer HealthCare AG
- 当前专利权人： Bayer HealthCare AG
- 当前专利权人地址： DE Leverkusen 51368
- 优先权： DE10328479.6 20030625
- 国际申请： PCT/EP04/06477 WO 20040616
- 主分类号： A61K31/513
- IPC分类号： A61K31/513 ; C07D239/14
摘要：
The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
公开/授权文献
- US07488733B2 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors 公开/授权日：2009-02-10